<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-viruses-12-00518">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Buckland</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Boulanger</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Fino</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Srivastava</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Holtz</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Khramtsov</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>McPherson</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Meghrous</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kubera</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Cox</surname>
    <given-names>M.M.</given-names>
   </name>
  </person-group>
  <article-title>Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process</article-title>
  <source>Vaccine</source>
  <year>2014</year>
  <volume>32</volume>
  <fpage>5496</fpage>
  <lpage>5502</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.07.074</pub-id>
  <pub-id pub-id-type="pmid">25131727</pub-id>
 </element-citation>
</ref>
